ResMed Inc. (RMD)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 2,957 | 3,197 | 3,578 | 4,223 | 4,685 | 5,146 | 5,653 | 5,653 |
| Operating profit | $m | 1,893 | 1,893 | ||||||
| Net profit | $m | 622 | 475 | 779 | 898 | 1,021 | 1,401 | 1,523 | 1,523 |
| EPS reported | $ | 10.40 | 10.40 | ||||||
| Operating cashflow per share | $ | 12.48 | 21.82 | ||||||
| Capex per share | $ | 1.08 | 1.85 | ||||||
| FCF per share | $ | 11.40 | 19.97 | ||||||
| Free cash flow | $m | 1,650 | 2,890 | ||||||
| Net debt | $m | -810 | -810 | ||||||
| Book value equity | $m | 6,585 | 6,585 | ||||||
| Book value per share | $ | 45.42 | 45.42 | ||||||
| Number of shares | m | 144.98 | 144.98 | ||||||
| DPS (TTM paid) | $ | 1.86 | 2.46 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 18.35 | 21.35 | ||||||
| P/B LTM | x | 4.28 | 5.75 | ||||||
| P/S LTM | x | 5.54 | 6.70 | ||||||
| P/FCF LTM | x | 17.10 | 13.10 | ||||||
| EV/EBITDA LTM | x | 11.64 | 17.47 | ||||||
| EV/Sales LTM | x | 4.74 | 5.65 | ||||||
| Earnings Yield LTM | % | +7.90% | +4.68% | ||||||
| FCF Yield | % | +5.85% | +7.63% | ||||||
| Quality | |||||||||
| ROE | % | +23.13% | +23.88% | ||||||
| ROIC | % | +19.11% | +19.11% | ||||||
| Operating margin | % | +33.48% | +33.48% | ||||||
| Gross margin | % | +61.16% | +61.16% | ||||||
| FCF/Sales | % | +29.18% | +51.11% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | +9.36% | +50.29% | ||||||
| Sales Growth YoY | % | +9.85% | +20.66% | ||||||
| Net Income Growth YoY | % | +8.75% | +49.20% | ||||||
| FCF Growth | % | -0.73% | +124.62% | ||||||
| Operating Profit Growth | % | +12.30% | +43.39% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | +1.24% | +1.07% | ||||||
| Dividend Growth | % | -17.70% | +21.78% | ||||||
| Payout Ratio | % | +23.19% | +40.18% | ||||||
| FCF/Debt | x | 2.00 | 3.50 | ||||||
| Net Debt/EBITDA | x | -0.30 | -0.30 | ||||||
| EBIT/Net interest | x | 65.20 | 65.20 | ||||||
| Net debt/market cap | % | +2.34% | +2.03% | ||||||
| Net debt/Equity | x | -0.12 | -0.12 | ||||||
| Gross debt/equity | x | 0.13 | 0.13 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free